Axol Bioscience

Axol is the first choice for high-quality, functionally relevant human derived iPSC-derived cells.

Powering advanced, more human-relevant in vitro disease models.

As drug discovery continues to explore more human-relevant approaches to disease modeling, human iPSC technology is gaining momentum. Using this technology, consented blood or skin donations from patients and healthy donors are ‘reprogrammed’ into a stem cell state, from which they can be turned into any cell type including neurons, neuroinflammatory cells, muscle cells and cardiac cells.

iPSC-derived cells can then be grown on their own (‘monocultures) or in mixtures (‘co-cultures’) of different cell types to make advanced in vitro models for research, toxicity studies and drug discovery. These models can be used to test compounds for safety and effectiveness.

High-quality iPSC-derived cells can be used to fuel robust, scalable in vitro human disease models to accelerate and de-risk drug discovery. 

At Axol Bioscience, they have spent the past decade developing the manufacturing capabilities to produce high-quality, functional iPSC-derived cells with excellent consistency. Your research can benefit from their quality-focused approach, with their catalog of robust, highly relevant iPSC-derived neurons and cardiomyocytes developed at their ISO 9001:2015-accredited production facility.

Their leading axoCellsTM cell types include:

  • Neurons: Cortical excitatory neurons, striatal neurons, cortical inhibitory interneurons, sensory neurons, motor neurons
  • Neuroinflammatory cells: Microglia, astrocytes
  • Cardiomyocytes: Atrial cardiomyocytes, ventricular cardiomyocytes
  • Muscle cells: Myotubes

Their iPSC-derived cells have been specifically developed to fuel advanced in vitro systems for drug discovery and drug safety.

They provide functional cells to explore:

  • Neuroscience: modeling neurodegenerative and neuroinflammatory diseases including ALS, Alzheimer’s disease and Huntington’s Disease
  • Pain and sensation: modeling pain and sensory function for drug discovery and neurotoxicity testing
  • Cardiovascular: using functional cardiomyocytes to model cardiac diseases (including arrhythmias) and for cardiotoxicity screening

More about Axol Bioscience

Newsletter for researchers

We gladly support you by keeping you updated on our latest products and the developments around our services.

we Connect you
Need help? Contact our technical support